Company witnessed QoQ revenue decline of 17.52%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 226.82% as compared to Nifty Smallcap 100 which gave a return of 55.24%. (as of last trading session)
Employee & Interest Expense
Company has spent 5.07% of its operating revenues towards interest expenses and 15.1% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Stock Returns vs Nifty Pharma
Stock generated 226.82% return as compared to Nifty Pharma which gave investors 52.86% return over 3 year time period. (as of last trading session)
Wanbury Ltd Share Price Update
Wanbury Ltd. share price moved down by -1.72% from its previous close of Rs 270.44. Wanbury Ltd. stock last traded price is 265.81
Share Price
Value
Today/Current/Last
265.81268.00
Previous Day
270.44271.15
InsightsWanbury
Do you find these insights useful?
hate it
meh
love it
Key Metrics
PE Ratio
(x)
19.84
EPS - TTM
(₹)
13.40
MCap
(₹ Cr.)
871.07
Sectoral MCap Rank
79
PB Ratio
(x)
31.70
Div Yield
(%)
0.00
Face Value
(₹)
10.00
Beta
Beta
1 Month
0.60
3 Months
0.43
6 Months
0.71
1 Year
1.08
3 Years
1.02
0.60
VWAP
(₹)
268.78
52W H/L
(₹)
323.53 / 131.20
BV/Share
(₹)
8.53
MCap/Sales
0.83
52W H/L
BV/Share
MCap/Sales
PE Ratio
(x)
20.00
EPS - TTM
(₹)
13.40
MCap
(₹ Cr.)
878.25
Sectoral MCap Rank
79
PB Ratio
(x)
31.75
Div Yield
(%)
0.00
Face Value
(₹)
10.00
Beta
Beta
1 Month
-0.25
3 Months
0.05
6 Months
0.32
1 Year
0.54
3 Years
0.89
-0.25
VWAP
(₹)
268.10
52W H/L
(₹)
325.00 / 132.55
BV/Share
(₹)
8.53
MCap/Sales
0.83
52W H/L
BV/Share
MCap/Sales
Key Metrics
PE Ratio
(x)
19.84
EPS - TTM
(₹)
13.40
Dividend Yield
(%)
0.00
VWAP
(₹)
268.78
PB Ratio
(x)
31.70
MCap
(₹ Cr.)
871.07
Face Value
(₹)
10.00
BV/Share
(₹)
8.53
Sectoral MCap Rank
79
52W H/L
(₹)
323.53 / 131.20
Beta
Beta
1 Month
0.60
3 Months
0.43
6 Months
0.71
1 Year
1.08
3 Years
1.02
0.60
MCap/Sales
0.83
PE Ratio
(x)
20.00
EPS - TTM
(₹)
13.40
Dividend Yield
(%)
0.00
VWAP
(₹)
268.10
PB Ratio
(x)
31.75
MCap
(₹ Cr.)
878.25
Face Value
(₹)
10.00
BV/Share
(₹)
8.53
Sectoral MCap Rank
79
52W H/L
(₹)
325.00 / 132.55
Beta
Beta
1 Month
-0.25
3 Months
0.05
6 Months
0.32
1 Year
0.54
3 Years
0.89
-0.25
MCap/Sales
0.83
Wanbury Ltd Share Price Returns
1 Day
-1.72%
1 Week
4.62%
1 Month
10.33%
3 Months
9.27%
1 Year
66.55%
3 Years
221.22%
5 Years
1019.2%
1 Day
-1.16%
1 Week
4.71%
1 Month
11.97%
3 Months
11.27%
1 Year
68.08%
3 Years
226.83%
5 Years
1028.42%
ET Stock ScreenersTop Score Companies
Check whether Wanbury Ltd belongs to analysts' top-rated companies list?
Company witnessed QoQ revenue decline of 17.52%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 5.07% of its operating revenues towards interest expenses and 15.1% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Company witnessed QoQ revenue decline of 17.52%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 5.07% of its operating revenues towards interest expenses and 15.1% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Increase in Cash from Investing
Company has used Rs 16.63 cr for investing activities which is an YoY increase of 88.12%. (Source: Consolidated Financials)
Rights ratio: 1 share for every 1 held at a price of Rs 10.0
About Wanbury
Wanbury Ltd., incorporated in the year 1988, is a Small Cap company (having a market cap of Rs 871.07 Crore) operating in Pharmaceuticals sector. Wanbury Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives and Scrap for the year ending 31-Mar-2023.For the quarter ended 31-12-2024, the company has reported a Consolidated Total Income of Rs 134.29 Crore, down 17.52 % from last quarter Total Income of Rs 162.82 Crore and down 8.14 % from last year same quarter Total Income of Rs 146.19 Crore. Company has reported net profit after tax of Rs 1.22 Crore in latest quarter.The company’s top management includes Mr.K Chandran, Mr.Mohan Kumar Rayana, Ms.Anupama Vaidya, Mr.Pravin Dilip Pawar, Mr.Mridul Sumanlal Mehta, Mr.Vinod Verma, Mr.Jitendra J Gandhi. Company has Kapoor & Parekh Associates as its auditors. As on 31-03-2025, the company has a total of 3.28 Crore shares outstanding.Wanbury Ltd Share Price Today is Rs. 265.81. On previous day, the Wanbury Ltd Share Price (NSE) closed at Rs. 263.47, featuring among the most traded securities on the National Stock Exchange.
Shareholdings: As of 31st Mar, 2025, the promoter held 39.76% of the stake in Wanbury Ltd shares, out of which 76.74% was pledged. On the same date, foreign institutional investors' (FII) holdings of Wanbury Ltd stocks was 0.84% as compared to 1.02% in Dec 2024 with decrease of 0.18%. The domestic institutional investors (DII) holdings on 31st Mar, 2025 was 0.0% as compared to 0.0% in Dec 2024 with decrease of 0.0%. Out of the total DII holdings in Wanbury Ltd shares 0.0% was held by mutual funds. The rest including public held is 59.4%. Wanbury Ltd stock price is reflected on both the exchanges - BSE and NSE.
Stock Forecast: After showing 134.29 Cr. of sales and 17.52% of quarterly net loss, there have been multiple ups and downs in the Wanbury Ltd stock prices in the past few weeks. For example, Wanbury Ltd stock price on 14th of April 2025 was around Rs. 238.56. Wanbury Ltd share price now stands at an average of Rs. 265.81. Judging by last week's performance, stock is in up trend.
Wanbury Ltd has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Wanbury Ltd share.
Historical Prices and Performance: Wanbury Ltd, incorporated in 1988 is a Small Cap company (with a market cap of Rs. 886.25) operating in Pharmaceuticals sector. The Return of Equity (ROE) in last five financial years given by Wanbury Ltd stock was 200.26%, 0.0%, -347.88%, 0.0% and -44.93% respectively. The Wanbury Ltd share gave a 3 year return of 220.81% as compared to Nifty 50 which gave a return of 38.71%. Wanbury Ltd announced 5.0% final dividend on February 20, 2006.
Key Metrics: PE Ratio of Wanbury Ltd is 19.66 Prices/Sales Ratio of Wanbury Ltd is 0.83 Price/Book Ratio of Wanbury Ltd is 30.89
Peer Insights: Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Wanbury Ltd, major competitors and peers include Kopran Ltd, Anuh Pharma, Medicamen Bio and Kilitch Drug. As of Dec 2024, the dividend yield of Wanbury Ltd stands at 0.0% while Kopran Ltd, Anuh Pharma, Medicamen Bio and Kilitch Drug stand at 1.5%, 1.44%, 0.21% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 19.66 and 30.89 respectively.
Leadership of Wanbury Ltd : Jitendra J Gandhi is Co. Secretary & Compl. Officer Vinod Verma is Chief Financial Officer K Chandran is Vice Chairman & Whole Time Dir Anupama Vaidya is Ind. Non-Executive Woman Director Mohan Kumar Rayana is Whole Time Director Pravin Dilip Pawar is Ind. Non-Executive Director Mridul Sumanlal Mehta is Addnl.Non Exe.Independent Director
Wanbury Ltd share price is Rs 265.81 as on 22 Apr, 2025, 03:56 PM IST. Wanbury Ltd share price is down by 1.72% based on previous share price of Rs. 240.65. In last 1 Month, Wanbury Ltd share price moved up by 10.33%.
2. What are the Wanbury Ltd quarterly results?
Total Revenue and Earning for Wanbury Ltd for the year ending 2024-03-31 was Rs 578.64 Cr and Rs 55.96 Cr on Consolidated basis. Last Quarter 2024-12-31, Wanbury Ltd reported an income of Rs 134.29 Cr and profit of Rs 1.22 Cr.
3. How can I quickly analyze Wanbury Ltd stock?
Key Metrics for Wanbury Ltd are:
Price to Book ratio of Wanbury Ltd is 31.70
4. What dividend is Wanbury Ltd giving?
An equity Final dividend of Rs 1 per share was declared by Wanbury Ltd. on 31 May 2010. So, company has declared a dividend of 10% on face value of Rs 10 per share. The ex dividend date was 29 Jul 2010.
5. Who's the owner of Wanbury Ltd?
Promoter holding have gone down from 39.79 (30 Jun 2024) to 39.76 (31 Mar 2025)
Domestic Institutional Investors holding has not changed in last 9 months and holds 0.0 stake as on 31 Mar 2025
Foreign Institutional Investors holding has gone up from 0.22 (30 Jun 2024) to 1.55 (31 Mar 2025)
Other investor holding have gone down from 59.99 (30 Jun 2024) to 58.69 (31 Mar 2025)
6. What are the returns for Wanbury Ltd share?
Return Performance of Wanbury Ltd Shares:
1 Week: Wanbury Ltd share price moved up by 4.62%
1 Month: Wanbury Ltd share price moved up by 10.33%
3 Month: Wanbury Ltd share price moved up by 9.27%
6 Month: Wanbury Ltd share price moved up by 14.77%
7. What is 52 week high/low of Wanbury Ltd share price?
In last 52 weeks Wanbury Ltd share had a high price of Rs 323.53 and low price of Rs 131.20
8. Who's the chairman of Wanbury Ltd?
K Chandran is the Vice Chairman & Whole Time Dir of Wanbury Ltd
9. What is the market cap of Wanbury Ltd?
Within the Pharmaceuticals sector, Wanbury Ltd stock has a market cap rank of 79. Wanbury Ltd has a market cap of Rs 871.07 Cr.
10. Who are the peers for Wanbury Ltd in Pharmaceuticals sector?
Within Pharmaceuticals sector Wanbury Ltd, Nectar Lifesciences Ltd., Kopran Ltd., Albert David Ltd., Medicamen Biotech Ltd., Medico Remedies Ltd., Ind-Swift Laboratories Ltd., Anuh Pharma Ltd., Zim Laboratories Ltd., Kilitch Drugs(I) Ltd. and Lyka Labs Ltd. are usually compared together by investors for analysis.
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.